The Neuropeptide Signalling Set groups Semax, Selank, BPC-157, NAD+ and Pinealon for cell based and ex vivo models of neurotransmission, neurotrophic support and synaptic plasticity. It is the broadest of the neuroscience sets in the NuVion range.
- Semax 10mg vial, a synthetic peptide built on an ACTH (4-10) fragment
- Selank 10mg vial, a synthetic heptapeptide derived from tuftsin
- BPC-157 10mg vial, a synthetic fragment modelled on a gastric protein sequence
- NAD+ 500mg vial, the coenzyme nicotinamide adenine dinucleotide
- Pinealon 20mg vial, a tripeptide (Glu-Asp-Arg) from the Khavinson series
Neuropeptide Signalling Set research applications
- BDNF and NTRK2 transcript measurement by qPCR in neuronal and glial culture, the Semax readout
- Radioligand binding on synaptic membrane preparations with tritiated GABA or muscimol, the Selank readout
- Reactive oxygen species assays with DCFH-DA in PC12 or SH-SY5Y cells (Pinealon) and sirtuin activity assays with fluorogenic substrates (NAD+)
Research profiles: Semax, Selank, BPC-157, NAD+ and Pinealon
What is tested in this set
This set contains five products, each supplied in its own vial and each tested on its own. The table lists the published result for every component.
| Component | Purity | Laboratory | Analysed | Certificate |
|---|---|---|---|---|
| Semax | 99.57% | Janoshik Analytical | 5 Feb 2026 | View |
| Selank | 99.89% | Janoshik Analytical | 10 Apr 2026 | View |
| BPC-157 | 99.93% | Janoshik Analytical | 24 Sep 2026 | View |
| NAD+ | 99.84% | Janoshik Analytical | 17 Oct 2025 | View |
| Pinealon | 99.39% | Janoshik Analytical | 23 Apr 2026 | View |










